Table 3.
Clinical and laboratory data for diabetic retinopathy patients with (Group A) and without (Group B) macular edema undergoing hemodialysis.
| Parameter | Group A (n = 19 eyes) |
Group B (n = 21 eyes) |
P value |
|---|---|---|---|
| Age (years) | 73.36 ± 9.10 | 69.86 ± 11.49 | 0.380 |
| Years of diabetic disease | 12.50 ± 6.32 | 12.27 ± 6.47 | 0.930 |
| Years of hemodialysis treatment | 3.07 ± 1.94 | 3.38 ± 2.50 | 0.718 |
| HbA1C (%) | 6.17 ± 1.12 | 6.81 ± 1.45 | 0.212 |
| Albumin (gram) | 38.79 ± 3.33 | 37.71 ± 3.24 | 0.397 |
| Kt/V—kinetic measure | 1.45 | 1.38 | 0.399 |
| Mean blood pressure difference (mm/Hg)—before and after hemodialysis | −4.92 ± 10.29 | +5.25 ± 8.79 | 0.016 |
| Weight difference (kg)—before and after hemodialysis | −1.92 ± 0.76 | −1.73 ± 0.81 | 0.534 |
Kt/V—kinetic measure as indicator of hemodialysis efficacy.